Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • $38.5 Million Bel Air Promontory Estate with Unobstructed Views of Los Angeles to Auction via Concierge Auctions World News
  • Latvia Achieves its First Safety Assessment Rating Aviation
  • Pressure Washing by National Softwash Restores Plainfield House Exteriors Business
  • ICE Releases Performance-Based National Detention Standards 2011 (April 2012) World News
  • UK Prime Minister Liz Truss announces mini-budget U-turn and new chancellor – BBC News World News
  • AV8 Realty Launches Partner Agent Network & Surpasses 400 Aviation Property Listings Nationwide, At EAA AirVenture Aviation
  • The ARON M80 Flying Ship Takes Flight Aviation
  • On the Passing of Judith Heumann World News

IF YOUR FINANCIAL ADVISOR RECOMMENDED NOVO NORDISK A/S INVESTMENTS PLEASE CONTACT KT LAW

Posted on February 14, 2025 By NewsEditor

If you suffered losses in Novo Nordisk S/A, Contact KT Law

KlaymanToskes Investigates on Behalf of Investors Who Were Recommended Novo Nordisk A/S Investments By Their Broker/Advisor

Novo Nordisk S/A (NYSE:NVO)

NEW YORK, NY, UNITED STATES, February 4, 2025 /EINPresswire.com/ — National investment loss and securities lawyers KlaymanToskes issues an important notice to investors who suffered significant losses in Novo Nordisk S/A (NYSE: NVO). The law firm urges customers of brokerage firms and financial advisors who suffered investment losses in excess of $100,000 in Novo Nordisk S/A to contact the firm immediately at 888-997-9956. Investors with self-directed accounts who did not rely on the advice of a financial advisor are not eligible for our representation.

KlaymanToskes is investigating brokerage firms and financial advisors that recommended investments in Novo Nordisk to their customers. On December 20, 2024, Novo Nordisk disclosed that only 57.3% of patients in its REDEFINE-1 trial were able to remain on the highest CagriSema dose, compared to 82.5% for cagrilintide and 70.2% for semaglutide. Following this news, Novo Nordisk’s stock plunged nearly 18%.

Our investigation has led the law firm to believe that investment firms and their financial advisors may have failed to act in the best interest of their customers, and misrepresented the risk-factors related to investments in Novo Nordisk S/A, in addition to failing to conduct due diligence on Novo Nordisk’s investment offering, leading to unsuitable recommendations.

Financial advisors and their firms may be held liable for any losses incurred by their customers in the event of failure to act in the best interest of the customer, unsuitable investment recommendations, misrepresentations or omissions of material facts, and/or an overconcentration of the customer’s portfolio in one particular investment, class, or market sector. Further, financial professionals and their firms cannot disregard a customer’s risk-tolerance when making investment recommendations.

Depending on your circumstances, you may be entitled to recover your losses through FINRA arbitration, which may result in a greater and additional recovery to solely participating and waiting for any recovery in any class action lawsuit.

Investors who suffered losses over $100,000 in Novo Nordisk S/A are encouraged to contact attorney Steven D. Toskes at (888) 997-9956 or by email at [email protected] in furtherance of our investigation. Investors with self-directed accounts who did not rely on the advice of a financial advisor are not eligible for our representation.

About KlaymanToskes

KlaymanToskes is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation on behalf of retail and institutional investors throughout the world in large and complex securities matters. The firm has recovered over $250 million in FINRA arbitrations and over $350 million in other securities litigation matters. KlaymanToskes has office locations in California, Florida, New York, and Puerto Rico.

Contact

Steven D. Toskes, Esq.
KlaymanToskes, P.A.
+1 888-997-9956
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

February 04, 2025, 15:57 GMT


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as IF YOUR FINANCIAL ADVISOR RECOMMENDED NOVO NORDISK A/S INVESTMENTS PLEASE CONTACT KT LAW

Business

Post navigation

Previous Post: Analyzing Growth Drivers, Market Share, Segments, Trends
Next Post: Saudia’s Chief Guest Experience Officer, Mr. Rossen Dimitrov, to Deliver Keynote at Airport Expansion Conference 2025

Related Posts

  • Loona Marks 1,000 Days of Bringing AI-Powered Companionship to 60,000+ Homes Business
  • Squeeze Claims #77 on Utah 100 Awards List for Fastest-Growing Companies Business
  • BongiTech Rebrands to Expand and Enhance Web Development Services Business
  • Equify Financial, LLC Continues the Expansion of Small-Ticket Dealer and Vendor Program Equipment Finance Business by Hiring National Sales Manager Greg Clemens Business
  • Corinium Global Intelligence Announces CDAO Fall 2025 in Boston, MA Business
  • A Retrospective Paintings Exhibition of the Song Dynasty on the occasion of the UN Chinese Language Day Business
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • The Assisted Reproductive Technology Market is to grow at a CAGR of 8.9%, reaching a value of $56.96 billion by 2030.November 16, 2026
  • Atopic Dermatitis Market Expected to Grow Steadily at a 14.6% CAGR Until 2030November 15, 2026
  • Forecast Report on the Semiconductor Chip Design Market Including Segment Analysis and Strategic Industry InsightsNovember 14, 2026
  • The Assisted Living Technologies Market is projected to grow to $17.76 billion by 2030, expanding at a CAGR of 13.8%November 14, 2026
  • Artificio Launches AI Agents That Work the SAP MRP Exception List Before Planners Start Their DayNovember 13, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Saudia’s Chief Guest Experience Officer, Mr. Rossen Dimitrov, to Deliver Keynote at Airport Expansion Conference 2025 Aviation
  • Not Only Putin Conf – What Does Putin Want, Alexey Arestovych’s speech in EU Parliament 2022 10 04
    Not Only Putin Conf – What Does Putin Want, Alexey Arestovych’s speech in EU Parliament 2022 10 04 World News
  • Salgenx Revolutionizes Battery Technology with Self-Assembly and Self-Healing Cathode Materials World News
  • Sinclair Technologies Announces 14-Port Small Cell Antenna of the New SSOP1 Series Business
  • Former President Joe Biden to Address National Bar Association at 100th Annual Awards Gala in Chicago World News
  • James Thulin Unveils EARTH CHIEF 2024 Silver Edition World News
  • Market Trends, Forecast, and Major Industry Players World News
  • The Future of Positive Cell Separation Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2026 195 News. All Rights Reserved by Coolaser

Powered by .